Below are certain reports and other statements that we file with the Securities and Exchange Commission. Select the filing type you wish to view from the menus below.
Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745
Interested in receiving investor news and updates?
Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.